CD36 and metabolic dysfunction-associated steatotic liver disease: In humans, CD36 deficiency, which is relatively common (2%–7%) in persons of Asian and African descent, has been reported to exhibit insulin resistance, atherosclerotic heart disease, hyperlipidemia, and a propensity to develop NAFLD and atherosclerotic heart disease.29